Dr. Goutman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Education & Training
- University of MichiganMS, Clinical Research and Statistics, 2013 - 2015
- Cleveland Clinic FoundationFellowship, Neuromuscular Medicine (Neurology), 2011 - 2012
- Cleveland Clinic FoundationResidency, Neurology, 2007 - 2011
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2007
Certifications & Licensure
- MI State Medical License 2012 - 2025
- OH State Medical License 2007 - 2013
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Clinical Trial of Ezogabine (Retigabine) in ALS Subjects Start of enrollment: 2015 Jun 01
- Genomic Translation for Amyotrophic Lateral Sclerosis Care Start of enrollment: 2016 Jun 08
- A Pilot Study of the Utility of 3D Printed Masks for ALS Subjects Start of enrollment: 2017 Mar 14
Publications & Presentations
PubMed
- Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD.Michael Benatar, Terry D Heiman-Patterson, Johnathan Cooper-Knock, Daniel Brickman, Kaitlin B Casaletto
Journal of Neurology, Neurosurgery, and Psychiatry. 2024-11-21 - 1 citationsEpigenetic age acceleration is associated with occupational exposures, sex, and survival in amyotrophic lateral sclerosis.Yue Zhao, Xiayan Li, Kai Wang, Gayatri Iyer, Stacey A Sakowski
Ebiomedicine. 2024-11-01 - Improving prediction models of amyotrophic lateral sclerosis (ALS) using polygenic, pre-existing conditions, and survey-based risk scores in the UK Biobank.Weijia Jin, Jonathan Boss, Kelly M Bakulski, Stephen A Goutman, Eva L Feldman
Journal of Neurology. 2024-10-01
Journal Articles
- Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral SclerosisBrian J Wainger, Nicholas J Maragakis, Richard Bedlack, Namita A Goyal, Seward B Rutkove, Michael H Rivner, Stephen A Goutman, Shafeeq S Ladha, Elizabeth A Mauricio, R..., JAMA Neurology
- Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Michael A Elliott, Samuel Maiser, Margaret A Owegi, Stephen A Goutman, Carlayne E Jackson, Jeffrey D Rothstein, Edward J Kasarskis, Liberty Jenkins, ..., The New England Journal of Medicine
Press Mentions
- ALS: Roberta Flack Says Disease Has Left Her Unable to SingNovember 16th, 2022
- Study Points to Jobs with Highest Risk for ALSSeptember 26th, 2022
- Neurologists Call for ALS Registry to Research Environmental Toxins Associated with DiseaseMay 7th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: